| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.051 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |